Her areas of focus are commercial strategy, growth strategy, and M&A for pharmaceutical, diagnostics, device, and consumer health companies, investors, and medical institutions worldwide. She also works with institutions and investors on their healthcare services strategies, diligences, and operations, including CROs, CMOs, clinical laboratory, health IT, hospital services, and clinical outreach. She is a leader in precision medicine and in clinical laboratory innovation, developing product and service strategies and operations with on-the-ground experience in North America, Latin America, Europe, Asia, India, the Middle East, and the Caribbean. Her book, Personalizing Precision Medicine, has garnered attention worldwide for its all-inclusive and comprehensive look at global precision medicine. Kristin joins KPMG from another Big Four firm where she was the Global Head of Life Sciences Strategy, responsible for growing the business from a single deals-focused office to a full service global strategy practice. Earlier in her career, she helped build Health Advances, a healthcare strategy firm now part of Parexel, and was a scientist and clinical diagnostics developer at Genome Therapeutics and Genzyme/Sanofi.